Hawaii SR 3: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN AND DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Status: Referred to HHS. (as of 2023-01-30)

State: Hawaii · Session: 2023 Regular Session · Bill: SR 3

Subjects: Department of Health, Medical Psilocybin and Psilocin Working Group

Sponsors: CHANG, RHOADS, McKelvey, Richards, Shimabukuro

View Hawaii SR 3 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.